Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 2 years
- Director since
- 2024
2 years of board service in total across 1 board, counting each seat separately. Longest: Bicara Therapeutics Inc., 2 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Bicara Therapeutics Inc. June 9, 202568.2%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 16, 2024 | Bicara Therapeutics Inc. | Derivative conversion | +4,327,365 | — | — |
| Sep 16, 2024 | Bicara Therapeutics Inc. | Derivative conversion | +1,080,775 | — | — |
| Sep 16, 2024 | Bicara Therapeutics Inc. | Derivative conversion | +324,552 | — | — |
| Sep 16, 2024 | Bicara Therapeutics Inc. | Derivative conversion | +432,736 | — | — |
Questions about Kiran Mazumdar-Shaw
What boards is Kiran Mazumdar-Shaw on?
Kiran Mazumdar-Shaw sits on the board of Bicara Therapeutics Inc.
How long has Kiran Mazumdar-Shaw served on boards?
Our records show at least 2 years of board service across 1 board, the earliest from 2024.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.